ETF Home ETF List Shorted Stocks Home About

Portfolio Holdings Detail for ISIN IE0002W8NB38
Stock Name / FundiShares MSCI USA Swap UCITS ETF USD (Acc)
IssuerBlackrock
Entity holding fund iShares VI Public Limited Company
Entity TypeUmbrella investment company with variable capital and having segregated liability between its funds
Entity LEI 549300VML6THE3JJOS76
ETF TickerMUSD(EUR) AS
ETF TickerMUSD(USD) Euronext Amsterdam
ETF TickerMUSA(EUR) Euronext Paris

Holdings detail for REGN

Stock NameRegeneron Pharmaceuticals Inc
TickerREGN(USD) NASDAQ
TYPECommon Stock
CountryUSA
ISINUS75886F1075
LEI549300RCBFWIRX3HYQ56

Show aggregate REGN holdings

News associated with REGN

Regeneron And Sanofi : CHMP Recommends EU Approval Of Dupixent For Chronic Spontaneous Urticaria
(RTTNews) - Regeneron Pharmaceuticals Inc. (REGN) and Sanofi announced that the European Medicines Agency's Committee for Medicinal Products for Human Use or CHMP has adopted a positive opinion recommending the approval of Dupixent (dupilumab) in the European Union for treating c - 2025-09-22 02:12:20
Peek Under The Hood: JEPQ Has 10% Upside
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-09-08 08:26:56
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Given Consensus Rating of “Moderate Buy” by Brokerages
Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Get Free Report) have been given an average recommendation of “Moderate Buy” by the twenty-six analysts that are currently covering the stock, Marketbeat.com reports. One analyst has rated the stock with a sell rating, six have issued a hold rating, sixteen have assigned a buy rating and three […] - 2025-08-26 02:16:48
LABU, INCY, UTHR, REGN: ETF Outflow Alert
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the Direxion Daily S&P Biotech Bull 3x Shares (Symbol: LABU) where we have detected an approximate $67.3 million dollar outflow -- that's a 9.4% dec - 2025-08-20 12:04:03
Regeneron Pharmaceuticals (NASDAQ:REGN) versus Cadrenal Therapeutics (NASDAQ:CVKD) Head-To-Head Analysis
Regeneron Pharmaceuticals (NASDAQ:REGN – Get Free Report) and Cadrenal Therapeutics (NASDAQ:CVKD – Get Free Report) are both medical companies, but which is the better investment? We will contrast the two companies based on the strength of their dividends, risk, analyst recommendations, valuation, institutional ownership, profitability and earnings. Volatility and Risk Regeneron Pharmaceuticals has a beta […] - 2025-08-20 02:22:48
Truist Financial Cuts Regeneron Pharmaceuticals (NASDAQ:REGN) Price Target to $812.00
Regeneron Pharmaceuticals (NASDAQ:REGN – Free Report) had its price target reduced by Truist Financial from $940.00 to $812.00 in a research note published on Monday,Benzinga reports. They currently have a buy rating on the biopharmaceutical company’s stock. REGN has been the topic of several other reports. The Goldman Sachs Group dropped their price target on […] - 2025-08-14 03:00:52
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Stock Position Raised by Blair William & Co. IL
Blair William & Co. IL lifted its position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 2.2% in the 1st quarter, Holdings Channel reports. The fund owned 1,282 shares of the biopharmaceutical company’s stock after buying an additional 27 shares during the period. Blair William & Co. IL’s holdings in Regeneron Pharmaceuticals were worth […] - 2025-08-11 06:26:50
Harbour Investments Inc. Sells 32 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)
Harbour Investments Inc. reduced its position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 7.4% in the first quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 403 shares of the biopharmaceutical company’s stock after selling 32 shares during the quarter. Harbour Investments Inc.’s holdings in […] - 2025-08-07 09:40:47
We Did The Math SPYX Can Go To $58
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-08-07 08:58:54
409 Shares in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Purchased by Arkadios Wealth Advisors
Arkadios Wealth Advisors purchased a new position in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) in the 1st quarter, according to its most recent filing with the Securities & Exchange Commission. The fund purchased 409 shares of the biopharmaceutical company’s stock, valued at approximately $259,000. Several other institutional investors and hedge funds also […] - 2025-08-07 05:38:53
Regeneron Pharmaceuticals (NASDAQ:REGN) Stock Price Expected to Rise, BMO Capital Markets Analyst Says
Regeneron Pharmaceuticals (NASDAQ:REGN – Get Free Report) had its price target upped by stock analysts at BMO Capital Markets from $600.00 to $640.00 in a research report issued on Monday,Benzinga reports. The firm currently has an “outperform” rating on the biopharmaceutical company’s stock. BMO Capital Markets’ price target indicates a potential upside of 12.30% from […] - 2025-08-06 03:12:48
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Receives $828.86 Consensus Target Price from Brokerages
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Get Free Report) has been given a consensus rating of “Moderate Buy” by the twenty-four ratings firms that are currently covering the firm, Marketbeat.com reports. One investment analyst has rated the stock with a sell recommendation, six have issued a hold recommendation, fifteen have assigned a buy recommendation and two […] - 2025-08-04 02:59:01
Stocks Slump on Tariffs and Weak US Job Growth
The S&P 500 Index ($SPX ) (SPY ) today is down -1.70%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -1.48%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -2.01%. September E-mini S&P futures (ESU25 ) are down -1.75%, and September E-mini Nasdaq futures... - 2025-08-01 19:31:54
Stocks Slump on Tariffs and Weak US Job Growth
The S&P 500 Index ($SPX ) (SPY ) today is down -1.70%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -1.48%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -2.01%. September E-mini S&P futures (ESU25 ) are down -1.75%, and September E-mini Nasdaq futures... - 2025-08-01 14:40:40
Stocks Slump on Tariffs and Weak US Job Growth
The S&P 500 Index ($SPX ) (SPY ) today is down -1.70%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -1.48%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -2.01%. September E-mini S&P futures (ESU25 ) are down -1.75%, and September E-mini Nasdaq futures... - 2025-08-01 14:35:36
Stocks Slump on Tariffs and Weak US Job Growth
The S&P 500 Index ($SPX ) (SPY ) today is down -1.70%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -1.48%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -2.01%. September E-mini S&P futures (ESU25 ) are down -1.75%, and September E-mini Nasdaq futures... - 2025-08-01 14:02:25
Nasdaq 100 Movers: MRVL, REGN
In early trading on Friday, shares of Regeneron Pharmaceuticals, topped the list of the day's best performing components of the Nasdaq 100 index, trading up 3.6%. Year to date, Regeneron Pharmaceuticals, has lost about 20.7% of its value. And the worst performing Nasdaq 100 co - 2025-08-01 11:30:09
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Shares Purchased by Choreo LLC
Choreo LLC boosted its holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 0.9% during the first quarter, according to its most recent Form 13F filing with the SEC. The fund owned 3,746 shares of the biopharmaceutical company’s stock after acquiring an additional 32 shares during the period. Choreo LLC’s holdings in Regeneron Pharmaceuticals […] - 2025-07-24 07:22:56
Crestwood Advisors Group LLC Grows Stock Holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)
Crestwood Advisors Group LLC increased its position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 5.7% in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 467 shares of the biopharmaceutical company’s stock after purchasing an additional 25 shares during the quarter. Crestwood Advisors Group […] - 2025-07-24 05:47:12
Kestra Private Wealth Services LLC Has $1.31 Million Stock Holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)
Kestra Private Wealth Services LLC grew its holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 6.9% in the first quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 2,058 shares of the biopharmaceutical company’s stock after buying an additional 132 shares during the quarter. […] - 2025-07-23 07:50:58
Larson Financial Group LLC Has $34,000 Stock Holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)
Larson Financial Group LLC lessened its position in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 34.6% during the 1st quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 53 shares of the biopharmaceutical company’s stock after selling 28 shares during the quarter. Larson […] - 2025-07-23 06:30:53
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Shares Purchased by Alps Advisors Inc.
Alps Advisors Inc. raised its position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 71.0% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 530 shares of the biopharmaceutical company’s stock after purchasing an additional 220 shares during the quarter. Alps Advisors Inc.’s […] - 2025-07-17 05:50:54
Stratos Wealth Partners LTD. Sells 115 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)
Stratos Wealth Partners LTD. trimmed its position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 18.5% in the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 506 shares of the biopharmaceutical company’s stock after selling 115 shares during the period. Stratos Wealth Partners […] - 2025-07-16 04:58:54
Allworth Financial LP Reduces Position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)
Allworth Financial LP trimmed its stake in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 14.3% in the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 821 shares of the biopharmaceutical company’s stock after selling 137 shares during the period. Allworth Financial […] - 2025-07-15 08:20:00
Regeneron Pharmaceuticals (NASDAQ:REGN) Price Target Raised to $584.00
Regeneron Pharmaceuticals (NASDAQ:REGN – Free Report) had its price target increased by UBS Group from $560.00 to $584.00 in a report issued on Friday,Benzinga reports. The brokerage currently has a neutral rating on the biopharmaceutical company’s stock. Several other research analysts also recently commented on REGN. BMO Capital Markets reduced their price objective on Regeneron […] - 2025-07-14 03:30:48
Brown Advisory Inc. Reduces Holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)
Brown Advisory Inc. lowered its stake in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 5.5% during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 4,269 shares of the biopharmaceutical company’s stock after selling 247 shares during the quarter. Brown Advisory Inc.’s […] - 2025-07-13 05:54:54
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Stock Holdings Cut by D.A. Davidson & CO.
D.A. Davidson & CO. reduced its position in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 2.8% in the first quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 732 shares of the biopharmaceutical company’s stock after selling 21 shares during the quarter. D.A. […] - 2025-07-11 05:32:52
Brokerages Set Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) PT at $813.57
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Get Free Report) has received an average recommendation of “Moderate Buy” from the twenty-five ratings firms that are covering the stock, MarketBeat reports. One research analyst has rated the stock with a sell rating, six have issued a hold rating, fifteen have assigned a buy rating and three have issued […] - 2025-07-10 03:07:00
DAVENPORT & Co LLC Makes New Investment in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)
DAVENPORT & Co LLC purchased a new position in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) during the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 427 shares of the biopharmaceutical company’s stock, valued at approximately $271,000. A number of other institutional […] - 2025-07-09 05:11:22
Bessemer Group Inc. Sells 3,860 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)
Bessemer Group Inc. decreased its position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 76.0% in the 1st quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 1,218 shares of the biopharmaceutical company’s stock after selling 3,860 shares during the period. Bessemer Group […] - 2025-07-01 05:46:52

iShares MSCI USA Swap UCITS ETF USD (Acc) REGN holdings

DateNumber of REGN Shares HeldBase Market Value of REGN SharesLocal Market Value of REGN SharesChange in REGN Shares HeldChange in REGN Base ValueCurrent Price per REGN Share HeldPrevious Price per REGN Share Held
2026-01-22 (Thursday)7,183REGN holding increased by 14366USD 5,426,828REGN holding increased by 10809265USD 5,426,82814,366USD 10,809,265 USD 755.51 USD 0
2026-01-22 (Thursday)-7,183REGN holding increased by 14366USD -5,426,828REGN holding increased by 10809265USD -5,426,82814,366USD 10,809,265 USD 755.51 USD 0
2026-01-21 (Wednesday)7,183REGN holding increased by 14366USD 5,382,437REGN holding increased by 10653179USD 5,382,43714,366USD 10,653,179 USD 749.33 USD 0
2026-01-21 (Wednesday)-7,183REGN holding increased by 14366USD -5,382,437REGN holding increased by 10653179USD -5,382,43714,366USD 10,653,179 USD 749.33 USD 0
2026-01-20 (Tuesday)7,183REGN holding increased by 14366USD 5,270,742REGN holding increased by 10536168USD 5,270,74214,366USD 10,536,168 USD 733.78 USD 0
2026-01-20 (Tuesday)-7,183REGN holding increased by 14366USD -5,270,742REGN holding increased by 10536168USD -5,270,74214,366USD 10,536,168 USD 733.78 USD 0
2026-01-19 (Monday)7,183REGN holding increased by 14366USD 5,265,426REGN holding increased by 10530852USD 5,265,42614,366USD 10,530,852 USD 733.04 USD 0
2026-01-19 (Monday)-7,183REGN holding increased by 14366USD -5,265,426REGN holding increased by 10530852USD -5,265,42614,366USD 10,530,852 USD 733.04 USD 0
2026-01-16 (Friday)7,183REGN holding increased by 14366USD 5,265,426REGN holding increased by 10594637USD 5,265,42614,366USD 10,594,637 USD 733.04 USD 0
2026-01-16 (Friday)-7,183REGN holding increased by 14366USD -5,265,426REGN holding increased by 10594637USD -5,265,42614,366USD 10,594,637 USD 733.04 USD 0
2026-01-15 (Thursday)7,183REGN holding increased by 14366USD 5,329,211REGN holding increased by 10746199USD 5,329,21114,366USD 10,746,199 USD 741.92 USD 0
2026-01-15 (Thursday)-7,183REGN holding increased by 14366USD -5,329,211REGN holding increased by 10746199USD -5,329,21114,366USD 10,746,199 USD 741.92 USD 0
2026-01-14 (Wednesday)7,183REGN holding increased by 14366USD 5,416,988REGN holding increased by 10868239USD 5,416,98814,366USD 10,868,239 USD 754.14 USD 0
2026-01-14 (Wednesday)-7,183REGN holding increased by 14366USD -5,416,988REGN holding increased by 10868239USD -5,416,98814,366USD 10,868,239 USD 754.14 USD 0
2026-01-13 (Tuesday)7,183REGN holding increased by 14366USD 5,451,251REGN holding increased by 10967795USD 5,451,25114,366USD 10,967,795 USD 758.91 USD 0
2026-01-13 (Tuesday)-7,183REGN holding increased by 14366USD -5,451,251REGN holding increased by 10967795USD -5,451,25114,366USD 10,967,795 USD 758.91 USD 0
2026-01-12 (Monday)7,183REGN holding increased by 14366USD 5,516,544REGN holding increased by 11238163USD 5,516,54414,366USD 11,238,163 USD 768 USD 0
2026-01-12 (Monday)-7,183REGN holding increased by 14366USD -5,516,544REGN holding increased by 11238163USD -5,516,54414,366USD 11,238,163 USD 768 USD 0
2026-01-09 (Friday)7,183REGN holding increased by 14366USD 5,721,619REGN holding increased by 11475274USD 5,721,61914,366USD 11,475,274 USD 796.55 USD 0
2026-01-09 (Friday)-7,183REGN holding increased by 14366USD -5,721,619REGN holding increased by 11475274USD -5,721,61914,366USD 11,475,274 USD 796.55 USD 0
2026-01-08 (Thursday)7,183REGN holding increased by 14366USD 5,753,655REGN holding increased by 11588190USD 5,753,65514,366USD 11,588,190 USD 801.01 USD 0
2026-01-08 (Thursday)-7,183REGN holding increased by 14366USD -5,753,655REGN holding increased by 11588190USD -5,753,65514,366USD 11,588,190 USD 801.01 USD 0
2026-01-07 (Wednesday)7,183REGN holding increased by 14366USD 5,834,535REGN holding increased by 11412422USD 5,834,53514,366USD 11,412,422 USD 812.27 USD 0
2026-01-07 (Wednesday)-7,183REGN holding increased by 14366USD -5,834,535REGN holding increased by 11412422USD -5,834,53514,366USD 11,412,422 USD 812.27 USD 0
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of REGN by Blackrock for IE0002W8NB38

Show aggregate share trades of REGN

DateActionQuantityMarket HighMarket LowLikely Trade PriceLikely Trade Value (Profit/Loss)Average Price previous trades
2026-01-22BUY14,366764.890747.370 749.122USD 10,761,887 634.35
2026-01-21BUY14,366749.550735.000 736.455USD 10,579,913 633.39
2026-01-20BUY14,366737.870718.380 720.329USD 10,348,246 632.55
2026-01-19BUY14,366 733.040* 631.69
2026-01-16BUY14,366749.090726.950 729.164USD 10,475,170 630.83
2026-01-15BUY14,366756.500738.620 740.408USD 10,636,703 629.87
2026-01-14BUY14,366766.640753.010 754.373USD 10,837,323 628.79
2026-01-13BUY14,366765.990743.940 746.145USD 10,719,119 627.65
2026-01-12BUY14,366811.090765.080 769.681USD 11,057,238 626.41
2026-01-09BUY14,366821.110790.930 793.948USD 11,405,857 624.89
2026-01-08BUY14,366816.990800.680 802.311USD 11,526,000 623.30
2026-01-07BUY14,366814.100780.100 783.500USD 11,255,762 621.58
2026-01-06BUY14,366785.405763.195 765.416USD 10,995,966 620.16
2026-01-05BUY14,366771.990753.199 755.078USD 10,847,456 618.84
2026-01-02BUY14,366779.750765.770 767.168USD 11,021,136 617.36
2025-12-31BUY14,366774.920769.170 769.745USD 11,058,156 615.91
2025-12-31BUY14,366774.920769.170 769.745USD 11,058,156 615.91
2025-12-30BUY14,366777.720770.305 771.046USD 11,076,854 614.40
2025-12-29BUY14,366784.990774.595 775.634USD 11,142,765 612.81
2025-12-26BUY14,366788.009778.090 779.082USD 11,192,291 611.13
2025-12-24BUY14,366792.770783.610 784.526USD 11,270,500 609.44
2025-12-24BUY14,366792.770783.610 784.526USD 11,270,500 609.44
2025-12-23BUY14,366792.750777.000 778.575USD 11,185,008 607.70
2025-12-22BUY14,366783.600765.090 766.941USD 11,017,875 605.99
2025-12-19BUY14,366773.850748.180 750.747USD 10,785,231 604.35
2025-12-18BUY14,366752.840739.230 740.591USD 10,639,330 602.88
2025-12-17BUY14,366751.990743.330 744.196USD 10,691,120 601.36
2025-12-16BUY11,327757.350734.720 736.983USD 8,347,806 599.85
2025-12-15BUY8,288756.660746.375 747.403USD 6,194,480 598.24
2025-12-12BUY8,288746.050734.380 735.547USD 6,096,214 596.72
2025-12-11BUY8,288753.565726.455 729.166USD 6,043,328 595.11
2025-12-10BUY8,288728.000692.500 696.050USD 5,768,862 593.68
2025-12-09BUY8,288711.000691.890 693.801USD 5,750,223 592.60
2025-12-08BUY8,288724.130701.745 703.983USD 5,834,615 591.37
2025-12-05BUY8,288736.150717.265 719.153USD 5,960,343 589.94
2025-12-04BUY8,288735.000721.220 722.598USD 5,988,892 588.43
2025-12-03BUY8,288744.225720.140 722.549USD 5,988,482 586.87
2025-12-02SELL-8,288747.000731.000 732.600USD -6,071,789 593.25 Loss of -1,154,958 on sale
2025-08-12BUY39,002556.550562.740 562.121USD 21,923,843 593.68
2025-08-11SELL-39,002545.940572.580 569.916USD -22,227,864 595.67 Profit of 1,004,487 on sale
2025-08-08BUY39,002563.000567.690 567.221USD 22,122,754 596.06
2025-08-07BUY39,002559.800565.480 564.912USD 22,032,697 596.51
2025-08-06BUY39,002555.130573.470 571.636USD 22,294,946 597.02
2025-08-05BUY39,002569.900579.820 578.828USD 22,575,450 597.36
2025-08-04BUY39,002571.540577.210 576.643USD 22,490,231 597.68
2025-08-01BUY39,002558.870583.280 580.839USD 22,653,884 598.18
2025-07-31BUY39,002545.460558.130 556.863USD 21,718,771 598.87
2025-07-30BUY39,002554.580563.590 562.689USD 21,945,997 599.45
2025-07-29BUY39,002558.150559.610 559.464USD 21,820,215 600.00
2025-07-28BUY39,002558.630567.950 567.018USD 22,114,836 600.56
2025-07-25BUY39,002563.100567.210 566.799USD 22,106,295 601.07
2025-07-24BUY39,002564.640577.730 576.421USD 22,481,571 601.58
2025-07-23BUY39,002572.390576.700 576.269USD 22,475,644 601.99
2025-07-22BUY39,002560.930563.000 562.793USD 21,950,053 602.57
2025-07-21BUY39,002545.530552.980 552.235USD 21,538,269 603.40
2025-07-18BUY39,002542.520550.890 550.053USD 21,453,168 604.30
2025-07-17BUY39,002550.000554.480 554.032USD 21,608,355 605.11
2025-07-16BUY39,002547.930558.350 557.308USD 21,736,126 605.97
2025-07-15BUY39,002547.960574.750 572.071USD 22,311,913 606.87
2025-07-14SELL-39,002570.590575.130 574.676USD -22,413,514 608.82 Profit of 1,331,824 on sale
2025-07-11BUY39,002567.740568.460 568.388USD 22,168,270 609.48
2025-07-10BUY39,002559.760566.370 565.709USD 22,063,782 610.28
2025-07-09BUY39,002552.580558.380 557.800USD 21,755,316 611.22
2025-07-08BUY39,002547.750559.460 558.289USD 21,774,388 612.28
2025-07-07BUY39,002538.110547.590 546.642USD 21,320,132 613.54
2025-07-04BUY39,002 547.360* 614.68
2025-07-03BUY39,002547.360555.000 554.236USD 21,616,312 615.86
2025-07-02BUY39,002547.740551.500 551.124USD 21,494,938 617.08
2025-06-30BUY39,002525.000526.080 525.972USD 20,513,961 618.75
2025-06-27BUY39,002521.000531.210 530.189USD 20,678,432 620.56
2025-06-26BUY39,002521.000524.520 524.168USD 20,443,601 622.44
2025-06-25BUY39,002520.290525.630 525.096USD 20,479,794 624.40
2025-06-24BUY39,002522.270527.450 526.932USD 20,551,402 626.41
2025-06-23BUY39,002511.920516.180 515.754USD 20,115,437 628.70
2025-06-20BUY39,002509.720521.310 520.151USD 20,286,929 631.12
2025-06-19BUY39,002 513.580* 633.57
2025-06-18BUY39,002513.580519.170 518.611USD 20,226,866 636.13
2025-06-17BUY39,002508.860523.010 521.595USD 20,343,248 638.89
2025-06-16BUY39,002522.680538.200 536.648USD 20,930,346 641.48
2025-06-13BUY39,002529.240529.550 529.519USD 20,652,300 644.03
2025-06-12BUY39,002521.840525.220 524.882USD 20,471,447 646.87
2025-06-11BUY39,002518.600528.370 527.393USD 20,569,382 649.92
2025-06-10BUY39,002523.530529.990 529.344USD 20,645,474 653.00
2025-06-09BUY39,002517.600518.270 518.203USD 20,210,954 656.39
2025-06-06BUY39,002493.220499.880 499.214USD 19,470,345 660.57
2025-06-04BUY39,002484.930499.900 498.403USD 19,438,714 665.20
2025-06-03BUY39,002487.860501.110 499.785USD 19,492,614 669.99
2025-06-02BUY39,002490.810502.560 501.385USD 19,555,018 674.97
2025-05-30BUY39,002490.280519.780 516.830USD 20,157,405 680.24
2025-05-29BUY39,002605.390605.730 605.696USD 23,623,355 682.44
2025-05-28BUY39,002591.850606.000 604.585USD 23,580,024 685.19
2025-05-27BUY39,002603.260608.170 607.679USD 23,700,696 687.75
2025-05-26BUY39,002 588.340* 690.96
2025-05-23BUY39,002588.340591.640 591.310USD 23,062,273 694.38
2025-05-22BUY39,002596.850605.500 604.635USD 23,581,974 697.74
2025-05-21SELL-39,002604.620617.520 616.230USD -24,034,203 707.13 Profit of 3,545,406 on sale
Market high and low price is on the date.

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of REGN

DateShorted VolumeShort Exempt VolumeTotal Shares Traded% Shorted
2025-09-19208,6591,635312,81266.7%
2025-09-18236,4853,679387,51961.0%
2025-09-17229,191716370,89561.8%
2025-09-16173,632584271,02064.1%
2025-09-15204,491251334,49661.1%
2025-09-12117,50433222,76052.7%
2025-09-11125,4783,137286,51643.8%
2025-09-10195,068481339,88557.4%
2025-09-09129,168994274,52047.1%
2025-09-08250,895396527,06247.6%
2025-09-05170,149290289,56658.8%
2025-09-04188,2272,103360,61952.2%
2025-09-03185,679344438,11142.4%
2025-09-02191,954138476,28840.3%
2025-08-29133,226685236,72656.3%
2025-08-28116,5602,177256,67545.4%
2025-08-27113,719465243,83646.6%
2025-08-26210,376450400,19952.6%
2025-08-25149,13068363,37741.0%
2025-08-22211,8223,244701,77030.2%
2025-08-21257,4923,416446,43957.7%
2025-08-20327,738572559,13358.6%
2025-08-19118,4722,191324,31136.5%
2025-08-18146,282388277,90952.6%
2025-08-15209,9233,375441,75247.5%
2025-08-14157,5693,623429,32736.7%
2025-08-13111,342233362,78630.7%
2025-08-12117,647171310,77537.9%
2025-08-11129,5132,676284,75745.5%
2025-08-08128,5591,038431,84129.8%
2025-08-07166,6481,560352,87747.2%
2025-08-06176,311624397,08944.4%
2025-08-05154,257115353,74443.6%
2025-08-04200,7581,913409,89749.0%
2025-08-01349,7753,745728,72048.0%
2025-07-31222,350476549,34440.5%
2025-07-30106,8391,689231,76146.1%
2025-07-29149,359276292,66751.0%
2025-07-28103,6871,380245,28742.3%
2025-07-25103,783556259,06940.1%
2025-07-24156,9742,397291,67753.8%
2025-07-23168,7341,708355,37247.5%
2025-07-22116,324617304,88038.2%
2025-07-2198,482900250,10739.4%
2025-07-18183,1741,051391,90946.7%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Note: All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability.

Copyright Market Footprint Ltd. Privacy Policy